Veeva：2023年卓越产品发布：生物制药的预商业路线图（英文版）

Research shows that companies' actions during clinical development,early commercialization, and product launch strongly determine drug salesperformance at launch and well into the future. Consider that 70% of productsthat miss launch expectations continue to underperform, while 80% of thosethat perform as expected meet or beat expectations in the future.1But, resource constraints, tight timelines, and fragmented technology solutionsmake launch execution challenging. Companies in the pre-c